Gilead Sciences reported $2.27B in Operating Profit for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US USD 5.5B 899M
Acorda Therapeutics ACOR:US USD 27.41M 32.4M
Agios Pharmaceuticals AGIO:US USD 28.68M 115.33M
ALKERMES ALKS:US USD -20582000 40.06M
Alnylam Pharmaceuticals ALNY:US USD -188614000 146.01M
Amgen AMGN:US USD 2.23B 508M
Biogen BIIB:US USD 699.9M 615.2M
Biomarin Pharmaceutical BMRN:US USD -24500000 22.08M
Bluebird Bio BLUE:US USD -84781000 22.62M
Bristol Myers Squibb BMY:US USD 1.94B 528M
Coherus Biosciences CHRS:US USD -51493000 28.96M
Eli Lilly And LLY:US USD 1.84B 159.9M
Gilead Sciences GILD:US USD 2.27B 570M
GlaxoSmithKline GSK:LN GBP 1.87B 677M
Glaxosmithkline GSK:US GBP 1.87B 677M
Intercept Pharmaceuticals ICPT:US USD -18024000 83.88M
Johnson & Johnson JNJ:US USD 4.2B 1.62B
Merk MRK:US USD 3.51B 505M
Moderna Inc MRNA:US USD 1.58B 414M
Neurocrine Biosciences NBIX:US USD 103.4M 15.6M
Novartis NOVN:VX USD 1.95B 219M
Pfizer PFE:US USD 5.17B 4.24B
Ptc Therapeutics PTCT:US USD -200341000 132.15M
Puma Biotechnology PBYI:US USD -2348000 4.72M
Regeneron Pharmaceuticals REGN:US USD 1.15B 76.9M
Sangamo Biosciences SGMO:US USD -55392000 498K
Sarepta Therapeutics SRPT:US USD -109408000 147.39M
Teva Pharmaceutical Industries TEVA:US USD -855000000 1.27B
United Therapeutics UTHR:US USD 175.6M 138.7M
Vertex Pharmaceuticals VRTX:US USD 1.03B 93.2M
YTE INCY:US USD 70.09M 68.28M